Monitor 505(b)(2) and biosimilar activity
- Anticipate 505(b)(2) and biosimilar approvals
- Track OTC-switches, new formulations, biosimilars, and other drug improvements
- Strengthen new formulation patents by studying prior claims and litigation
Refine Your Market-Entry Strategy
- Assess market potential through historic sales figures
- Evaluate buyer power with data on reimbursement segmentation
- Align distribution methods with information on where and how drugs are purchased
Find and Evaluate Business Opportunities
- Assess levels of generic competition
- Use drug price ranges to evaluate price elasticity
- Determine optimal prices before launch
Global Drug Patents
- Drug Patents in 134 Countries
- Evaluate branded and generic market opportunities globally
Get Confidential Royalty and Settlement Terms
- Study failed patent challenges to develop a better strategy
- Collect competitive intelligence by examining contractual disputes
- Track litigation to anticipate early generic entry
Find Generic Drug Entry Opportunities
- Inform portfolio management decisions
- Sector landscaping and due diligence
- Track drugs in development and explore new indications for existing drugs
Serving leading biopharmaceutical companies globally:
